scispace - formally typeset
P

Patrick A. Baeuerle

Researcher at Amgen

Publications -  314
Citations -  59914

Patrick A. Baeuerle is an academic researcher from Amgen. The author has contributed to research in topics: T cell & Antigen. The author has an hindex of 115, co-authored 305 publications receiving 57875 citations. Previous affiliations of Patrick A. Baeuerle include University of Freiburg & Ludwig Maximilian University of Munich.

Papers
More filters
Journal ArticleDOI

Chlorate a potent inhibitor of protein sulfation in intact cells

TL;DR: The effect of chlorate on protein sulfation in intact cells was investigated and chlorate treatment provides a powerful tool for studying the biological significance ofprotein sulfation.
Journal ArticleDOI

The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.

TL;DR: It is reported that nanomolar concentrations of gliotoxin inhibited the activation of transcription factor NF-kappaB in response to a variety of stimuli in T and B cells, raising the possibility that the immunosuppression observed during aspergillosis results in part from gliot toxin-mediated NF- kappaB inhibition.
Journal ArticleDOI

DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition.

TL;DR: A comparative analysis of known NF-kappa B-binding sites and competition experiments with synthetic polynucleotides and oligonucleotide encompassing only one half-site or single-stranded kappa B motifs suggested that the two DNA-binding monomers in the NF-Kappa B protein complex can interact differentially with the half-sites of the decameric cognate motif.
Journal ArticleDOI

Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody

TL;DR: In this article, the authors explored the in vitro efficacy, T-cell donor variability, binding characteristics, specificity, kinetics and interleukin-2 (IL-2) dependence of bispecific antibody (bscCD19xCD3) against human B lymphoma cell lines.